KR101775682B1 - 보툴리눔 독소의 제조방법 - Google Patents

보툴리눔 독소의 제조방법 Download PDF

Info

Publication number
KR101775682B1
KR101775682B1 KR1020150168196A KR20150168196A KR101775682B1 KR 101775682 B1 KR101775682 B1 KR 101775682B1 KR 1020150168196 A KR1020150168196 A KR 1020150168196A KR 20150168196 A KR20150168196 A KR 20150168196A KR 101775682 B1 KR101775682 B1 KR 101775682B1
Authority
KR
South Korea
Prior art keywords
botulinum toxin
exchange chromatography
anion exchange
precipitate
buffer solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020150168196A
Other languages
English (en)
Korean (ko)
Other versions
KR20170062694A (ko
Inventor
김경윤
김청세
김명섭
설혜영
Original Assignee
주식회사 대웅
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to KR1020150168196A priority Critical patent/KR101775682B1/ko
Application filed by 주식회사 대웅 filed Critical 주식회사 대웅
Priority to BR112018007679A priority patent/BR112018007679A2/pt
Priority to PCT/KR2016/013506 priority patent/WO2017095062A1/en
Priority to CA2997698A priority patent/CA2997698C/en
Priority to MX2018004650A priority patent/MX2018004650A/es
Priority to RU2018113925A priority patent/RU2707255C1/ru
Priority to US15/758,042 priority patent/US10619143B2/en
Priority to JP2018540360A priority patent/JP6574528B2/ja
Priority to CN201680061642.XA priority patent/CN108350043B/zh
Priority to AU2016364597A priority patent/AU2016364597B2/en
Priority to EP16870958.2A priority patent/EP3383889A4/en
Priority to ARP160103642A priority patent/AR107218A1/es
Priority to TW105139480A priority patent/TWI623549B/zh
Publication of KR20170062694A publication Critical patent/KR20170062694A/ko
Application granted granted Critical
Publication of KR101775682B1 publication Critical patent/KR101775682B1/ko
Priority to AU2019201315A priority patent/AU2019201315B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361Ion-exchange
    • B01D15/362Cation-exchange
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361Ion-exchange
    • B01D15/363Anion-exchange
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • B01D61/145Ultrafiltration
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • B01D61/147Microfiltration
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/58Multistep processes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/30Extraction; Separation; Purification by precipitation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24069Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2315/00Details relating to the membrane module operation
    • B01D2315/16Diafiltration

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Water Supply & Treatment (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1020150168196A 2015-11-30 2015-11-30 보툴리눔 독소의 제조방법 Active KR101775682B1 (ko)

Priority Applications (14)

Application Number Priority Date Filing Date Title
KR1020150168196A KR101775682B1 (ko) 2015-11-30 2015-11-30 보툴리눔 독소의 제조방법
EP16870958.2A EP3383889A4 (en) 2015-11-30 2016-11-23 PROCESS FOR THE PREPARATION OF BOTULINUM TOXIN
CA2997698A CA2997698C (en) 2015-11-30 2016-11-23 Method for producing botulinum toxin
MX2018004650A MX2018004650A (es) 2015-11-30 2016-11-23 Metodo para producir toxina botulinica.
RU2018113925A RU2707255C1 (ru) 2015-11-30 2016-11-23 Способ получения ботулотоксина
US15/758,042 US10619143B2 (en) 2015-11-30 2016-11-23 Method and producing botulinum toxin
JP2018540360A JP6574528B2 (ja) 2015-11-30 2016-11-23 ボツリヌス毒素の製造方法
CN201680061642.XA CN108350043B (zh) 2015-11-30 2016-11-23 用于产生肉毒杆菌毒素的方法
BR112018007679A BR112018007679A2 (pt) 2015-11-30 2016-11-23 método para produzir uma toxina botulínica
PCT/KR2016/013506 WO2017095062A1 (en) 2015-11-30 2016-11-23 Method for producing botulinum toxin
AU2016364597A AU2016364597B2 (en) 2015-11-30 2016-11-23 Method for producing botulinum toxin
ARP160103642A AR107218A1 (es) 2015-11-30 2016-11-29 Método para producir toxina botulínica
TW105139480A TWI623549B (zh) 2015-11-30 2016-11-30 肉毒桿菌毒素製造方法
AU2019201315A AU2019201315B2 (en) 2015-11-30 2019-02-26 Method for producing botulinum toxin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020150168196A KR101775682B1 (ko) 2015-11-30 2015-11-30 보툴리눔 독소의 제조방법

Publications (2)

Publication Number Publication Date
KR20170062694A KR20170062694A (ko) 2017-06-08
KR101775682B1 true KR101775682B1 (ko) 2017-09-06

Family

ID=58797138

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020150168196A Active KR101775682B1 (ko) 2015-11-30 2015-11-30 보툴리눔 독소의 제조방법

Country Status (13)

Country Link
US (1) US10619143B2 (enExample)
EP (1) EP3383889A4 (enExample)
JP (1) JP6574528B2 (enExample)
KR (1) KR101775682B1 (enExample)
CN (1) CN108350043B (enExample)
AR (1) AR107218A1 (enExample)
AU (2) AU2016364597B2 (enExample)
BR (1) BR112018007679A2 (enExample)
CA (1) CA2997698C (enExample)
MX (1) MX2018004650A (enExample)
RU (1) RU2707255C1 (enExample)
TW (1) TWI623549B (enExample)
WO (1) WO2017095062A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8129139B2 (en) 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
JP5951490B2 (ja) * 2009-10-21 2016-07-13 ルバンス セラピュティックス インク.Revance Therapeutics,Inc. 非複合ボツリヌス神経毒素を精製するための方法およびシステム
KR101723168B1 (ko) * 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR102463881B1 (ko) * 2016-10-04 2022-11-07 (주)메디톡스 보툴리눔 독소 함유 용액으로부터 보툴리눔 독소를 분리하는 방법
KR102516203B1 (ko) * 2019-04-15 2023-03-30 (주)제테마 보툴리눔 독소의 제조방법
KR102516204B1 (ko) * 2019-04-15 2023-03-30 (주)제테마 보툴리눔 독소의 정제방법
EP3962924A1 (en) * 2019-05-03 2022-03-09 Genentech, Inc. Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform
KR102287437B1 (ko) * 2019-08-14 2021-08-09 주식회사 프로톡스 보툴리눔 독소의 제조방법
TW202136286A (zh) * 2019-12-20 2021-10-01 瑞士商葛德瑪控股公司 純化肉毒桿菌毒素的方法
CN112480221A (zh) * 2020-12-02 2021-03-12 湖北省农业科学院畜牧兽医研究所 产气荚膜梭菌毒素抗原浓缩工艺
KR102724651B1 (ko) * 2021-07-08 2024-11-01 주식회사 파마리서치바이오 비-독소 단백질이 제거된 클로스트리디움 보툴리눔 신경독소 단백질의 정제방법
CO2023018742A1 (es) * 2023-12-29 2025-07-07 Lifefactors S A S Proceso de purificación de macromoléculas con etapas de precipitación selectiva, concentración y diálisis combinadas en condiciones constantes de estabilidad con el cual se obtienen formulaciones estables y de alta pureza

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060228780A1 (en) * 2003-09-25 2006-10-12 Allergan, Inc. Chromatographic method and system for purifying a botulinum toxin
JP2011074025A (ja) * 2009-09-30 2011-04-14 Chemo-Sero-Therapeutic Research Inst ボツリヌス毒素の精製方法
US20120245324A1 (en) * 2009-07-13 2012-09-27 Allergan, Inc. Process for obtaining botulinum neurotoxin
KR101339349B1 (ko) * 2013-08-02 2013-12-09 주식회사 대웅 보툴리눔 독소의 제조방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06192296A (ja) 1992-10-28 1994-07-12 Chiba Pref Gov 治療用医薬品としての結晶a型ボツリヌス毒素の製造法。
JPH06199296A (ja) 1992-12-29 1994-07-19 Toyota Motor Corp ガスタービンエンジンを推進力とする水上飛行機
DE19925739A1 (de) * 1999-06-07 2000-12-21 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Therapeutikum mit einem Botulinum-Neurotoxin
GB9914743D0 (en) * 1999-06-24 1999-08-25 Knoll Ag Therapeutic agents
KR20030060150A (ko) * 2002-01-07 2003-07-16 (주)메디톡스 클로스트리디움 보툴리눔 a형 독소를 정제하는 방법
CN1930186A (zh) * 2005-03-03 2007-03-14 阿勒根公司 为获得梭菌毒素的梭菌细菌培养基及方法
KR101025617B1 (ko) 2008-02-25 2011-03-30 메덱스젠 주식회사 클로스트리디움 보툴리눔으로부터 보툴리눔 독소를정제하는 방법
KR20090120222A (ko) * 2008-05-19 2009-11-24 (주)메디톡스 식물 유래 성분 함유 배지 및 가요성 폐쇄 용기를 이용하여클로스트리디움 보툴리눔 독소를 생산하는 방법
JP5951490B2 (ja) 2009-10-21 2016-07-13 ルバンス セラピュティックス インク.Revance Therapeutics,Inc. 非複合ボツリヌス神経毒素を精製するための方法およびシステム
KR101134146B1 (ko) * 2010-05-31 2012-04-19 메덱스젠 주식회사 국소 근마비 효과를 갖는 비확산형 보툴리눔 독소와 그의 정제방법
UY33452A (es) 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060228780A1 (en) * 2003-09-25 2006-10-12 Allergan, Inc. Chromatographic method and system for purifying a botulinum toxin
US20120245324A1 (en) * 2009-07-13 2012-09-27 Allergan, Inc. Process for obtaining botulinum neurotoxin
JP2011074025A (ja) * 2009-09-30 2011-04-14 Chemo-Sero-Therapeutic Research Inst ボツリヌス毒素の精製方法
KR101339349B1 (ko) * 2013-08-02 2013-12-09 주식회사 대웅 보툴리눔 독소의 제조방법

Also Published As

Publication number Publication date
CA2997698C (en) 2021-04-20
AU2019201315B2 (en) 2020-10-15
TW201726703A (zh) 2017-08-01
CN108350043A (zh) 2018-07-31
TWI623549B (zh) 2018-05-11
AU2016364597B2 (en) 2019-01-17
MX2018004650A (es) 2018-08-15
BR112018007679A2 (pt) 2018-11-06
US10619143B2 (en) 2020-04-14
RU2707255C1 (ru) 2019-11-25
JP6574528B2 (ja) 2019-09-11
WO2017095062A1 (en) 2017-06-08
US20180251741A1 (en) 2018-09-06
AU2019201315A1 (en) 2019-03-21
CA2997698A1 (en) 2017-06-08
KR20170062694A (ko) 2017-06-08
AR107218A1 (es) 2018-04-11
AU2016364597A1 (en) 2018-04-12
EP3383889A1 (en) 2018-10-10
EP3383889A4 (en) 2019-07-17
CN108350043B (zh) 2022-06-14
JP2018533977A (ja) 2018-11-22

Similar Documents

Publication Publication Date Title
KR101775682B1 (ko) 보툴리눔 독소의 제조방법
KR101819129B1 (ko) 비-복합체화된 보툴리눔 신경독소를 정제하기 위한 방법 및 시스템
MX2013014773A (es) Procedimiento de purificacion de formas nativas o mutantes de la toxina difterica.
KR102516204B1 (ko) 보툴리눔 독소의 정제방법
JP2024513914A (ja) バイオコンジュゲート生産のためのプロセス
US20220267368A1 (en) Method for preparing botulinum toxin
JPWO2020129986A1 (ja) ボツリヌス毒素の製造方法
TWI890364B (zh) 使用多模式層析法純化肉毒毒素的改進方法
JP7680099B2 (ja) 非毒素タンパク質が除去されたクロストリジウム・ボツリヌス神経毒素タンパク質の精製方法
JP2023507653A (ja) ボツリヌス毒素の精製方法
CN113121638B (zh) 一种纯化重组蛋白的方法
TWI839783B (zh) 提高純化收率的肉毒桿菌毒素複合物的純化方法
HK40064407A (en) Method for purifying botulinum toxin

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

A302 Request for accelerated examination
PA0302 Request for accelerated examination

St.27 status event code: A-1-2-D10-D17-exm-PA0302

St.27 status event code: A-1-2-D10-D16-exm-PA0302

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PX0701 Decision of registration after re-examination

St.27 status event code: A-3-4-F10-F13-rex-PX0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9